127 related articles for article (PubMed ID: 34338562)
1. Progranulin and tumor necrosis factor-alpha in lean polycystic ovary syndrome patients.
Uzdogan A; Kuru Pekcan M; Cil AP; Kisa U; Akbiyik F
Gynecol Endocrinol; 2021 Oct; 37(10):925-929. PubMed ID: 34338562
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome.
Pawelczak M; Rosenthal J; Milla S; Liu YH; Shah B
J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):356-9. PubMed ID: 25256873
[TBL] [Abstract][Full Text] [Related]
3. Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome.
Choi YS; Yang HI; Cho S; Jung JA; Jeon YE; Kim HY; Seo SK; Lee BS
Steroids; 2012 Nov; 77(13):1352-8. PubMed ID: 22944040
[TBL] [Abstract][Full Text] [Related]
4. Serum progranulin to TNF-α ratio in patients with gonarthrosis.
Yıldız K; Boy F
Acta Orthop Traumatol Turc; 2021 May; 55(3):235-238. PubMed ID: 34100364
[TBL] [Abstract][Full Text] [Related]
5. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome.
Nehir Aytan A; Bastu E; Demiral I; Bulut H; Dogan M; Buyru F
Gynecol Endocrinol; 2016 Sep; 32(9):709-713. PubMed ID: 26951881
[TBL] [Abstract][Full Text] [Related]
6. Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study.
Yousuf SD; Rashid F; Mattoo T; Shekhar C; Mudassar S; Zargar MA; Ganie MA
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):58-62. PubMed ID: 27381237
[TBL] [Abstract][Full Text] [Related]
7. Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors.
Barcellos CR; Rocha MP; Hayashida SA; Dantas WS; Dos Reis Vieira Yance V; Marcondes JA
Hormones (Athens); 2015; 14(2):251-7. PubMed ID: 26158655
[TBL] [Abstract][Full Text] [Related]
8. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
Souza Dos Santos AC; Soares NP; Costa EC; de Sá JC; Azevedo GD; Lemos TM
Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
[TBL] [Abstract][Full Text] [Related]
9. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
[TBL] [Abstract][Full Text] [Related]
10. Is there an interaction between polycystic ovary syndrome and gingival inflammation?
Özçaka Ö; Ceyhan BÖ; Akcali A; Biçakci N; Lappin DF; Buduneli N
J Periodontol; 2012 Dec; 83(12):1529-37. PubMed ID: 22509751
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of PGRN protein in follicular fluid and mRNA in granulosa cells in overweight patients with polycystic ovary syndrome.
Zhou D; Li S; Li W; Yin T; Xu W; Zhang J; Yang J
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():106-112. PubMed ID: 28964971
[TBL] [Abstract][Full Text] [Related]
12. Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA
Korean J Intern Med; 2013 Jul; 28(4):456-63. PubMed ID: 23864804
[TBL] [Abstract][Full Text] [Related]
13. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
14. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
15. A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome.
Kume T; Calan M; Yilmaz O; Kocabas GU; Yesil P; Temur M; Bicer M; Calan OG
J Endocrinol Invest; 2016 Jul; 39(7):747-54. PubMed ID: 26969461
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tumor necrosis factor alpha serum level in obese and lean women with clomiphene citrate-resistant polycystic ovary disease.
Seyam E; Hasan M; Khalifa EM; Ramadan A; Hefzy E
Gynecol Endocrinol; 2017 Nov; 33(11):892-898. PubMed ID: 28480767
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women.
Yousuf SD; Ganie MA; Urwat U; Andrabi SM; Zargar MA; Dar MA; Manzoor-Ul-Rehman M; Mudassar S; Rashid F
BMC Womens Health; 2023 Feb; 23(1):68. PubMed ID: 36793022
[TBL] [Abstract][Full Text] [Related]
18. Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome.
González F; Kirwan JP; Rote NS; Minium J
Am J Obstet Gynecol; 2014 Dec; 211(6):635.e1-7. PubMed ID: 24956549
[TBL] [Abstract][Full Text] [Related]
19. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
Ezeh U; Pall M; Mathur R; Azziz R
Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
[TBL] [Abstract][Full Text] [Related]
20. The effects of circuit resistance training on plasma progranulin level, insulin resistance and body composition in obese men.
Safarzade A; Alizadeh H; Bastani Z
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32146440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
